WEF aims to push birth control during ER visits

A World Economic Forum (WEF) initiative is currently probing how best to convince women who visit emergency departments (EDs) to use birth control, regardless of the reasons for their visits.

Operatives from the WEF Women’s Health Initiative noted in a report last month that approximately 20 million women and girls “of childbearing age seek care in EDs annually” in the US. Given that other “interventions” such as vaccinations have higher success rates when pitched to ER patients, the WEF is seeking to add life-prevention to the list.

“EDs offer great potential for reaching women worldwide with family planning information and services, which can ultimately help reduce unintended pregnancies and improve reproductive and sexual health outcomes on a global scale,” says the WEF. 

To achieve this goal, the globalist organization says it is “listening” to how women and girls would prefer to be pitched birth prevention during an ER visit. Through an organization called the White Ribbon Alliance, the WEF is gathering data from focus groups on how and when to persuade women in ERs on birth prevention — including possibly administering it on the spot.

White Ribbon Alliance has published a guide for facilitating such focus groups, which it notes should include 6–10 participants ages 18–44 who are “comfortable talking about birth control.” Each participant should be a “woman or non-binary (with ability to menstruate).”

The focus group guide includes an introductory script for the facilitator which explains that the WEF is exploring ways to get women on birth control when they visit the ED “regardless of the reason the woman is there”:

The Women’s Health Initiative at the World Economic Forum is working with women across the U.S. to come up with new ideas for reaching women who want birth control. One of these ideas is to provide birth control information and services in the emergency department (the “ED”). Regardless of the reason the woman is there, it may be a good place and time to have this conversation. Most emergency departments don’t currently offer birth control counseling or services, like prescriptions or method placement. But given this is a place where many women and their families get healthcare, we are exploring whether it’s a good opportunity.

Focus group participants are then asked a series of questions such as how comfortable they would be receiving information about birth control at an ER, what they would change about ERs to make them more conducive towards birth control discussions, from which staff member they would prefer to receive information, at which point during the ER process they would prefer to have the discussion, and if they would be comfortable receiving a prescription for birth control on the spot.

The WEF’s initiative is part of a larger coordinated effort by hundreds of governments, organizations and pharmaceutical companies to foist life prevention products on women and girls globally. 

In July 2012, a meeting in London was convened by the US Agency for International Development (USAID), the Bill and Melinda Gates Foundation, the UK Department for International Development (DFID), and the United Nations Population Fund (UNFPA). The goal of the meeting was “to empower the voluntary use of modern contraception by 120 million additional women and girls in the world’s lowest-income countries by 2020.” An organization called Family Planning 2020 (FP2020) was formed.

FP2020 soon recruited over 130 governments, organizations and corporations to join the cause. Drug companies like Pfizer and Bayer pledged to provide birth preventive products all around the world. 

As 2020 approached, FP2020’s founders evidently deemed it so successful that they renewed it for another decade and renamed the organization FP2030. Its globalist managers include North America and Europe Managing DIrector Monica Kerrigan, MPH, who previously worked for Planned Parenthood, the Gates Foundation and USAID, which is understood to be a propaganda tool for the Central Intelligence Agency (CIA).

In 2021, FP2030 received $1.4 billion from government funding alone, with over $500 million from USAID each year.

When starting a birth prevention campaign in a target country, FP2030’s founding organizations first contact an official in that country’s Health Ministry. They present the official with a strategy containing high-impact practices (HIPs) for preventing births on a mass scale and provide them with the funds to do it.

However, FP2030’s goal is not simply to make birth prevention devices available, but to convince women to take them. Therefore, any mass birth prevention strategy must “improve attitudes.” 

One of the main vehicles used for changing minds and attitudes towards birth prevention is mass media. In a 2016 High Impact Practices Partners’ meeting attended by FP2030 operatives, organizations were encouraged to “[u]se one or more mass media channels (radio, TV, print) to increase knowledge, improve attitudes and self-efficacy, and encourage social change to effect family planning.”

Another part of the strategy is to use gender confusion ideology to prevent mass births. Whereas men and women naturally breed, masculinizing women and effeminizing men — in contravention of “gender norms” — is an effective way to stagnate a population.

“For FP2030, an intentional approach to gender equality makes our work more effective in advancing both family planning and gender equality,” says an FP2030 presentation titled “FP2030 Gender Strategy.”

The organization plainly states that “[g]ender norms . . . create barriers to FP access” and that “[w]ith greater funding and scale, gender-transformative approaches will advance gender equality and accelerate progress on contraceptive access and use.”

In countries where birth prevention rates are stagnant, FP2030 says gender ideology, or “positive gender norms”, can be “more effective”:

In countries where contraceptive prevalence has plateaued, demand-side interventions promoting positive gender norms can be more effective than supply‑side approaches.

The Gender Strategy notes that feminist operatives are also very helpful in driving birth prevention.

This may also explain why US intelligence agencies are heavily funding gender confusion around the globe through “Pride” organizations and events.

Such gender confusion — where women are masculinized and men are effeminized — is also achieved by birth prevention drugs themselves. According to scientific evidence, women who take birth prevention pills are likely to find more effeminate men attractive and themselves less attractive. They are also more likely to be sexually dissatisfied and cheat on their partners. If the woman wants to conceive, she can cease taking the pill which may make her lose interest in her partner, potentially fragmenting the family if a child is conceived.

The desire among globalists to prevent births is aggressive. Even though certain birth preventive injections can increase the risk of HIV, the World Health Organization (WHO) still recommends it be provided to women.

“WHO advises that women should not be denied the use of progestogen-only injectables because of concerns about the possible increased [HIV] risk,” reads an FP2020 report. Women should be made aware of the increased risk of HIV, it continues, but they should also be told there is “uncertainty over a causal relationship.”

Vaccination is also included in FP2030's mass birth prevention strategy.

Nepal’s government, for instance, “is developing an integrated care strategy that includes family planning and immunization integration. Progress is being made on ensuring that post-abortion family planning is regularly offered.” FP2030 funds to Nepal also go towards “employing mass media to reach youth, ethnic minorities, and marginalized and disadvantaged groups with family planning information.”

Ultimately, FP2030 has been successful. One in three women of reproductive age is now using birth prevention products, boasts the organization, with the sharpest increase in Sub-Saharan Africa. As of July 2022, an estimated 371 million women and girls around the world are using birth prevention.

Notably, this is in addition to birth prevention products used by men.